Automated Anesthesia Guided by the Conox Monitor for Surgery
Launched by CMC AMBROISE PARÉ · May 17, 2018
Trial Information
Current as of May 19, 2025
Terminated
Keywords
ClinConnect Summary
Several monitors are currently proposed to evaluate the depth of hypnosis. The Conox monitor differentiates itself from the other brain monitor by calculating two EEG indexes, the qCon and the qNox. The qCon corresponds to the depth of the sedation and the qNox relates to the probability that a nociceptive stimulation triggers a movement of the patient. A controller allowing the automated titration of propofol guided by the qCon and remifentanil guided by the qNox has been developed. In preparation for a large multi-center control trial, this prospective randomized study evaluates the effec...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Scheduled surgery for at least one hour
- • Consent for participation
- • Affiliation to the social security system
- Exclusion Criteria:
- • Pregnant or breastfeeding women
- • Patients for which Conox monitor should not be used
- • Allergies to propofol or remifentanil
About Cmc Ambroise Paré
CMC Ambroise Paré is a distinguished clinical trial sponsor dedicated to advancing medical research and innovation. With a focus on enhancing patient care, the organization specializes in the development and management of clinical trials across various therapeutic areas. CMC Ambroise Paré is committed to rigorous scientific standards, ensuring compliance with regulatory requirements while fostering collaboration among healthcare professionals, researchers, and stakeholders. By leveraging cutting-edge methodologies and a patient-centric approach, the organization aims to contribute to the development of safe and effective treatments, ultimately improving health outcomes and quality of life.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Besançon, Bourgogne Franche Comté, France
Suresnes, Ile De France, France
Soyaux, Poitou Charentes, France
Patients applied
Trial Officials
Marc Fischler, MD
Study Chair
Hôpital Foch
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials